NVMI vs TRMB
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
Nova Ltd. exhibits strong fundamental health with a Piotroski F-Score of 7/9 and exceptional liquidity (Current Ratio 6.28), yet it faces a severe valuation disconnect. The current price of $517.43 is significantly higher than both the Graham Number ($86.52) and the growth-based Intrinsic Value ($236.59). While the company boasts a stellar 25-quarter earnings beat track record and strong profitability margins, the bearish insider sentiment and a very low technical trend score (10/100) suggest a potential peak. The stock is currently priced for perfection, leaving little margin for error despite its 'Strong Buy' analyst consensus.
Trimble Inc. presents a stark contrast between deterministic health metrics and analyst optimism. The Piotroski F-Score of 3/9 indicates weak financial health, and the current price of $69.50 trades at a significant premium to both the Graham Number ($31.29) and the Intrinsic Value ($51.92). While the company shows impressive earnings growth (80.50% YoY) and strong gross margins, stagnant revenue growth and bearish insider activity suggest caution. The stock is currently priced for a recovery that is not yet fully supported by the fundamental health scorecard.
Compare Another Pair
Related Comparisons
NVMI vs TRMB: Head-to-Head Comparison
This page compares Nova Ltd. (NVMI) and Trimble Inc. (TRMB) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.